Document:

DC7150.pdf -- Converted by SEC Publisher 4.2, created by BCL Technologies Inc., for SEC Filing

AMENDMENT NO. 1 TO

STOCKHOLDER PROTECTION RIGHTS AGREEMENT

     This Amendment No. 1 to Stockholder Protection Rights Agreement (this “Amendment”) is made and entered into as of July 21, 2009, by
and between Fuel Systems Solutions, Inc. (the “Company”) and Mellon Investor Services LLC (the “Rights Agent”).

	
RECITALS

     WHEREAS, the Company and the Rights Agent, formerly known as ChaseMellon Shareholder Services, L.L.C., entered into a certain Stockholder Protection Rights Agreement (the “Rights Agreement”), dated as of June 27, 2006, whereby the Rights Agent was appointed to act as agent for the Company and the holders of the Rights (as defined in the Rights Agreement);

     WHEREAS, pursuant to Sections 1.1 and 5.2 of the Rights Agreement, the Rights expire on July 22, 2009 unless action is taken by the Company to extend their expiration date; and

     WHEREAS, the Board of the Directors of the Company believes it is in the best interest of the Company and its shareholders to amend the Rights Agreement to extend the expiration date of the Rights to
July 22, 2019 and has accordingly approved such amendment.

     NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:

Section 1. Amendment to the Rights Agreement.

     (a) The expiration date of the Rights shall be extended to July 22, 2019. Accordingly, the definition of “Expiration Time” in Section 1.1 of the Rights Agreement shall be amended and
restated in its entirety to read as follows:

“Expiration Time” shall mean the earliest of (i) the Exchange Time, (ii) the Redemption Time, (iii) the Close of Business on July 22, 2019 and (iv) immediately
prior to the effective time of a consolidation, merger or share exchange of the Company (A) into another Person or (B) with another Person in which the Company is the surviving Person but Common Stock is converted into cash and/or securities of
another corporation, in either case pursuant to an agreement entered into by the Company prior to a Stock Acquisition Date.

     (b) The penultimate sentence of Section 2.6(a) of the Rights Agreement shall be amended and restated in its entirety to read as follows: 

Promptly after the Company learns of the Separation Time, the Company will notify the Rights Agent in writing of such Separation Time and will deliver Rights Certificates duly executed by the Company to the Rights

Agent for counter-signature, and, subject to Section 3.1(b), the Rights Agent shall, either manually or by facsimile, countersign and deliver such Rights Certificates to the holders of the Rights pursuant to Section 2.3(c)
hereof.

     (c) The ultimate sentence of Section 3.1(b) of the Rights Agreement shall be amended and restated in its entirety to read as follows:

If any Rights Certificate is presented for assignment or exercise and the Person presenting the same will not complete the certification set forth at the end of the form of assignment or notice of election to exercise and provide
such additional evidence of the identity of the Beneficial Owner and its Affiliates and Associates (or former Beneficial Owners and their Affiliates and Associates) as the Company or the Rights Agent shall reasonably request, then the Company shall
be entitled conclusively to deem the Beneficial Owner thereof to be an Acquiring Person or an Affiliate or Associate thereof or a transferee of any of the foregoing and accordingly will deem the Rights evidenced thereby to be null and void and not
transferable or exercisable.

     (d) Section 4.3(g) of the Rights Agreement shall be amended to include the following sentence as its ultimate sentence:

The Rights Agent shall be fully authorized and protected in relying upon the most recent instructions received by such Person.

     (e) Section 4.4(b) of the Rights Agreement shall be amended and restated in its entirety to read as follows:

(b) an Affiliate of a Person described in clause (a) of this sentence that is under control of such Person.

     (f) Section 5.5 of the Rights Agreement shall be amended to include the following paragraph as its ultimate paragraph:

Whenever a payment for fractional Rights or fractional shares is to be made by the Rights Agent under any section of this Agreement, the Company shall (i) promptly prepare and deliver to the Rights Agent a certificate setting
forth in reasonable detail the facts related to such payment and the prices and/or formulas utilized in calculating such payments, and (ii) provide sufficient monies to the Rights Agent in the form of fully collected funds to make such payments. The
Rights Agent shall be fully protected in relying upon such a certificate and shall have no duty with respect to, and shall not be deemed to have knowledge of any payment for fractional Rights or fractional shares under any Section of this Agreement
relating to the payment of fractional Rights or fractional shares

unless and until the Rights Agent shall have received such a certificate and sufficient monies. 

     (g) Section 5.18 of the Rights Agreement shall be amended and restated in its entirety to read as follows: 

Severability. If any term or provision hereof or the application thereof to any circumstance shall, in any jurisdiction and to any extent, be invalid or unenforceable, such term or provision shall
be ineffective as to such jurisdiction to the extent of such invalidity or unenforceability without invalidating or rendering unenforceable the remaining terms and provisions hereof or the application of such term or provision to circumstances other
than those as to which it is held invalid or unenforceable; provided, however, that if such excluded provision shall affect the rights, immunities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign
immediately.

     (h) The Rights Agreement shall be amended to include the following as Section 5.19:

Force Majeure.  Notwithstanding anything to the contrary contained herein, the Rights Agent shall not be liable for any delays or failures in performance resulting from acts beyond its reasonable
control including, without limitation, acts of God, terrorist acts, shortage of supply, breakdowns or malfunctions, interruptions or malfunction of computer facilities, or loss of data due to power failures or mechanical difficulties with
information storage or retrieval systems, labor difficulties, war, or civil unrest.

     Section 2. Certification. The Company hereby certifies to the Rights Agent that this Amendment is in compliance with Section 5.4 of the
Rights Agreement.

     Section 3. Governing Law. This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes
shall be governed by and construed by and construed in accordance with the laws of such state applicable to contracts to be made and performed entirely within such state; provided, however, that all provisions regarding the rights, duties and
obligations of the Rights Agent shall be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed entirely within such state.

     Section 4. Counterparts.  This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

     Section 5. No Further Amendment. Except as specifically amended above, the terms and provisions of the Rights Agreement, as amended, shall
remain otherwise unchanged and in full force and effect.

     IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.

	
FUEL SYSTEMS SOLUTIONS, INC.

	
By: _/s/ Matthew Beale________________

Matthew Beale

President and Chief Financial Officer

	
MELLON INVESTOR SERVICES LLC,

as Rights Agent

	
By: _/s/ Mark Cano___________________

Mark Cano

BNY Mellon Shareowner ServicesForm of Note Amendment and Release of Collateral

 Exhibit 4.1 
 NOTE AMENDMENT AND RELEASE OF COLLATERAL 
 This Note Amendment and Release of Collateral is made as of this
20th day of July, 2009 by and among Cardium Therapeutics, Inc., a Delaware corporation (the “Company”), and holders (each a “Holder”) of a senior subordinated secured promissory notes issued pursuant to the terms of
that certain Note and Warrant Purchase Agreement dated February 27, 2009 (“Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Notes. 
 W I T N E S S E T H 
 WHEREAS, the
Company issued and sold an aggregate principal amount of $3,500,000 of senior subordinated secured promissory notes pursuant to the Purchase Agreement, of which an aggregate principal amount of $2,550,000 of such notes are dated February 27,
2009 and an aggregate principal amount of $950,000 of such notes are dated March 5, 2009, and each of which were amended by certain Amendments to Promissory Notes dated as of June 23, 2009 and July 10, 2009 by and among the Company
and the Holders (such senior subordinated secured promissory notes as amended are referred to herein as the “Notes”); 
 WHEREAS,
pursuant to the terms of a Security Agreement dated as of February 27, 2009 (the “Security Agreement”), by and among the holders of the Notes, the Company, InnerCool Therapies, Inc., a Delaware corporation and wholly-owned
subsidiary of the Company (“InnerCool”), Tissue Repair Company, a Delaware corporation and wholly-owned subsidiary of the Company, and Dr. Robert Marshall as collateral agent (the “Collateral Agent”) payment of
the Notes is secured by, among other things, a lien on the assets of InnerCool (the “InnerCool Assets”); 
 WHEREAS, on July 10,
2009, the Company and InnerCool entered into an Asset Purchase Agreement (the “Philips APA”) with Philips Electronics North America Corporation, a Delaware corporation (“Philips”), pursuant to which Philips will
purchase substantially all of the InnerCool Assets (the “Philips Transaction”), and the Company and Holders wish to facilitate the consummation of the Philips Transaction, pursuant to which the InnerCool Assets are to be acquired by
Philips free and clear of any liens created by the Security Agreement or otherwise; 
 WHEREAS, certain Holders of the Notes wish to take advantage of
an offer by the Company to extend the term of all or a portion of their Note as set forth in Section 2 below (the “Optional Term Extension”) in exchange for the receipt of the following payments (collectively the “Term
Extension Payments”): 
  

	a)	A first payment at the time of Closing of the Philips Transaction (the “First Payment”) comprising the sum of the following: (i) all currently accrued but
unpaid interest on their Note; (ii) a Note Origination Fee (as defined in the Note); plus (iii) at the Holder’s election, up to 50% of the outstanding principal of the Note; 

  

	b)	Continuing monthly interest payments following the consummation of the Philips Transaction (the “Monthly Payments”) comprising monthly interest on the outstanding
principal balance of their Note at the rate of Twelve Percent (12%) per annum; and 

  

 1 

	c)	A final payment (the “Final Pay-Off Amount”), due no later than November 5, 2009, and comprising any remaining accrued but unpaid interest plus the outstanding
principal balance of their Note. 

 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto hereby agree as follows: 
 1. Acknowledgement and Note Extension. Holder acknowledges that each holder of
Notes is being afforded an opportunity to individually elect to extend the maturity of such holder’s Note to November 5, 2009 and to otherwise modify and amend such Note as set forth in Section 2 below. In addition, Holder and the
Company agree that, effective as of the date hereof, all of the Notes shall be amended as follows: 
 1.1 Section 3 of each Note
is hereby amended to read in its entirety as follows: 
 3. Maturity. Unless sooner paid in accordance with the terms
hereof, the entire unpaid principal amount and all unpaid accrued interest shall become fully due and payable on the earlier of (i) July 23, 2009, or (ii) the acceleration of the maturity of this Note by the Holder upon the occurrence
of an Event of Default (such earlier date, the “Maturity Date”). 
 1.2 Section 5(a)(i) of each Note is hereby amended
to delete the words “twenty-three (23) days” and in place thereof insert the words “two (2) Business Days” so that Section 5(a)(i) of the Note shall read in its entirety as follows: 
 (i) any indebtedness under this Note is not paid when and as the same shall become due and payable, whether at maturity, by acceleration,
thirty-five (35) days following notice of prepayment or otherwise, and any such amount shall remain unpaid for a period of two (2) Business Days after the due date thereof 
 2. Optional Term Extension; Term Extension Payments. 
 Please indicate below whether you wish to have this
Section 2 apply to your Note in exchange for which you will be entitled to receive the Optional Term Extension Payments (including the First Payment, Monthly Payments and Final Pay-Off Amount as described above), with respect to that portion of
your Note that you elect to extend (minimum amount for extension 50%). 
  

			
	  
             

	 	 Yes – I wish to have the provisions of this Section 2 apply to my Note and to receive the corresponding Optional Term Extension Payments with
respect to the following portion of my Note:
  
     % of
Principal to be extended (minimum amount 50%)
  

	            	 	No – I decline to have the provisions of this Section 2 apply to my Note.

  

 2 

 2.1 Note Extension and Amendments. The Company and the undersigned holder agree that,
subject to payment of the First Payment, the Note shall be amended as follows: 
 (a) Section 3 of the Note shall be amended to
read in its entirety as follows: 
 3. Maturity. Unless sooner paid in accordance with the terms hereof, the entire
unpaid principal amount and all unpaid accrued interest shall become fully due and payable on the earlier of (i) November 5, 2009, or (ii) the acceleration of the maturity of this Note by the Holder upon the occurrence of an Event of
Default (such earlier date, the “Maturity Date”). 
 (b) Section 4(b) of the Note shall be amended to read in its
entirety as follows: 
 (b) Interest Payments. The Company shall pay to Holder accrued interest and unpaid interest on
the last Business Day of each month commencing with July 31, 2009 and on the Maturity Date. Interest at the rate first set forth above shall accrue on any interest which has not been paid on the date on which it is payable until such time as
payment therefor is actually delivered to Holder. 
 (c) Section 4(c) of the Note shall be deleted in its entirety. 

2.2 Release of Collateral. The Holder hereby consents to the transactions contemplated by the Philips APA and waives any violation or
default of Transaction Documents (as defined in the Purchase Agreement) that might otherwise arise by reason thereof. In connection therewith, upon satisfaction of the Effectiveness Conditions, Holder approves, and hereby directs the Collateral
Agent to effectuate, the release of any and all liens on the Collateral (as defined in the Security Agreement) to be conveyed to Philips pursuant to the Philips APA. 
 2.3 Timing. The parties hereto contemplate that the amounts payable as part of the Effectiveness Conditions shall be paid at the closing of the transactions contemplated by the Philips APA. To remove any
doubt arising from the order in which transactions may take place, the parties hereto agree that any transactions contemplated hereby and by the Philips APA, if occurring on the same day, shall be deemed to have occurred simultaneously. 

3. Execution in Counterparts. This Note Amendment and Release of Collateral may be executed in any number of counterparts, each of which when so
executed and delivered shall be deemed an original, and such counterparts together shall constitute one instrument. Delivery by facsimile or other electronic means of an executed counterpart hereof shall have the same force and effect as delivery of
an originally executed counterpart hereof. 
 [Signatures on next page] 
  

 3 

 IN WITNESS WHEREOF, the undersigned, by their duly authorized representatives, have executed this Note Amendment and
Release of Collateral as of the date first above written. 
  

			
	Company:
	
	CARDIUM THERAPEUTICS, INC.
		
	By:	 	 /s/    Tyler Dylan

		 	Tyler Dylan, Chief Business Officer, General Counsel, Executive Vice President and Secretary

  

			
	Holder:	 	
	  

	(Print Name of Individual or Entity)
		
	By:	 	  

		 	(Signature)
		
	Name:	 	  

	Title:	 	  

	
	Principal Amount of Note: $        
	
	AGREED AND ACKNOWLEDGED:
	
	 /s/    Dr. Robert Marshall

	Dr. Robert Marshall, as Collateral Agent

  

 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}]]